About
Neursantys stands at the forefront of non-invasive bioelectronics, addressing neuromotor and neurocognitive conditions lacking widespread pharmacological solutions. Our flagship product platform, NEURVESTA, delivers the world's first restorative neuroplastic treatment for age-related balance decline, a medical condition that is now known to begin as early as age 40 and affect over 70 million people in Canada and the U.S. alone.
Technologies
Outlook
Microsoft Office 365
Google Cloud Hosting
WordPress.org
Nginx
Eventbrite
Bootstrap Framework
Google Font API
Mobile Friendly
Remote
Domo
Sisense
KNIME
Keywords
agetech
bioelectonics
neuroscience
sportstech
space medicine
medical equipment manufacturing
clinical research
medical equipment and supplies manufacturing
digital health
government
digital healthcare innovation
microgravity health solutions
neuroplasticity waveforms
services
machine learning biomarkers
wearable neurostimulation device
space-microgravity health solutions
space medicine applications
remote patient monitoring
vestibular system stimulation
neurostimulation
deep space healthcare
medical technology
personalized neuromotor therapy
neuroplasticity therapy
elderly care technology
remote diagnostics
wearable balance diagnostics
bioelectronic biomarkers
bioelectronic device
Company Information
-
Employees 6
-
Founded 2022
Location
659 Oak Grove Ave, Menlo Park, California, United States, 94025-4317
